BMJ open improving the management of multimorbidity in general practice: Protocol of a cluster randomised controlled trial (The 3D Study)

BMJ Open

Volumn 6, Issue 4, 2016, Pages

  Man, Mei See ^a   Chaplin, Katherine ^a   Mann, Cindy ^a   Bower, Peter ^b   Brookes, Sara ^a   Fitzpatrick, Bridie ^c   Guthrie, Bruce ^d   Shaw, Alison ^a   Hollinghurst, Sandra ^a   Mercer, Stewart ^c   Rafi, Imran ^e   Thorn, Joanna ^a   Salisbury, Chris ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PAIN; CLINICAL PROTOCOL; CLUSTER ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; ECONOMIC EVALUATION; EFFECT SIZE; GENERAL PRACTICE; HEALTH CARE DELIVERY; HUMAN; LIFE EXPECTANCY; MEDICATION COMPLIANCE; MENTAL HEALTH; MORBIDITY; MULTICENTER STUDY; NEOPLASM; PATIENT CARE; PATIENT SAFETY; POLYPHARMACY; PRIMARY MEDICAL CARE; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESOURCE ALLOCATION; RHEUMATOID ARTHRITIS; SECONDARY HEALTH CARE; TREATMENT WITHDRAWAL; ADOLESCENT; ADULT; CHRONIC DISEASE; CLINICAL TRIAL; COMORBIDITY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DISEASE MANAGEMENT; FEMALE; MALE; METHODOLOGY; UNITED KINGDOM;

ADOLESCENT; ADULT; CHRONIC DISEASE; CLINICAL PROTOCOLS; COMORBIDITY; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DISEASE MANAGEMENT; FEMALE; GENERAL PRACTICE; HUMANS; MALE; PATIENT-CENTERED CARE; QUALITY OF LIFE; RESEARCH DESIGN; UNITED KINGDOM;

EID: 84970016748     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-011261     Document Type: Article

References (48)

1. Salisbury C, Johnson L, Purdy S, et al. Epidemiology and impact of multimorbidity in primary care: A retrospective cohort study. Br J Gen Pract 2011;61:e12-e21.
2. Barnett K, Mercer S, Norbury M, et al. The epidemiology of multimorbidity in a large cross-sectional dataset: implications for health care, research and medical education. Lancet 2012;380:37-43.
3. Lawson KD, Mercer SW, Wyke S, et al. Double trouble: The impact of multimorbidity and deprivation on preference-weighted health related quality of life a cross sectional analysis of the Scottish Health Survey. Int J Equity Health 2013;12:67.
4. Bayliss EA, Edwards AE, Steiner JF, et al. Processes of care desired by elderly patients with multimorbidities. Fam Pract 2008;25:287-93.
5. Noël PH, Chris Frueh B, Larme AC, et al. Collaborative care needs and preferences of primary care patients with multimorbidity. Health Expect 2005;8:54-63.
6. Bayliss EA, Ellis JL, Steiner JF. Barriers to self-management and quality-of-life outcomes in seniors with multimorbidities. Ann Fam Med 2007;5:395-402.
7. Hughes LD, McMurdo ME, Guthrie B. Guidelines for people not for diseases: The challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing 2013;42:62-9.
8. Marcum ZA, Gellad WF. Medication adherence to multidrug regimens. Clin Geriatr Med 2012;28:287-300.
9. Bourgeois FT, Shannon MW, Valim C, et al. Adverse drug events in the outpatient setting: An 11-year national analysis. Pharmacoepidemiol Drug Saf 2010;19:901-10.
10. Guthrie B, Payne K, Alderson P, et al. Adapting clinical guidelines to take account of multimorbidity. BMJ 2012;345:e6341.
11. Dumbreck S, Flynn A, Nairn M, et al. Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ 2015;350:h949.
12. Chew-Graham CA, Hunter C, Langer S, et al. How QOF is shaping primary care review consultations: A longitudinal qualitative study. BMC Fam Pract 2013;14:103.
13. Glynn LG, Valderas JM, Healy P, et al. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract 2011;28:516-23.
14. Smith SM, Okelly S, Odowd T. GPs' and pharmacists' experiences of managing multimorbidity: A Pandora's box. Br J Gen Pract 2010;60:e285-94.
15. Obrien R, Wyke S, Guthrie B, et al. An 'endless struggle': A qualitative study of general practitioners' and practice nurses' experiences of managing multimorbidity in socio-economically deprived areas of Scotland. Chronic Illn 2011;7:45-59.
16. Sinnott C, Mc Hugh S, Browne J, et al. GPs' perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research. BMJ Open 2013;3:e003610.
17. Smith SM, Soubhi H, Fortin M, et al. Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ 2012;345:e5205.
18. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: The new Medical Research Council guidance. BMJ 2008;337:a1655.
19. Stewart M. Towards a global definition of patient centred care. BMJ 2001;322:444-5.
20. American Geriatric Society Expert Panel. Patient-centered care for older adults with multiple chronic conditions: A stepwise approach from the American Geriatrics Society: American Geriatrics Society expert panel on the care of older adults with multimorbidity. J Am Geriatr Soc 2012;60:1957-68.
21. Mead N, Bower P. Patient-centredness: A conceptual framework and review of the empirical literature. Soc Sci Med (1982) 2000;51:1087-110.
22. Wagner EH, Austin BT, Von KM. Improving outcomes in chronic illness. Manag Care Q 1996;4:12-25.
23. Coulter A, Roberts S, Dixon A. Delivering better services for people with long-term conditions: building the house of care. Secondary delivering better services for people with long-term conditions: building the house of care 2013. http://www.kingsfund.org.uk/sites/files/kf/field/field-publication-file/delivering-better-servicesfor-people-with-long-term-conditions.pdf.
24. Health and Social Care Information Centre. Quality and Outcomes Framework. 2015. http://www.hscic.gov.uk/qof (accessed 10 Oct 2015).
25. Salisbury C. Multimorbidity: redesigning health care for people who use it. Lancet 2012;380:7-9.
26. Salisbury C. Multimorbidity: Time for action rather than words. Br J Gen Pract 2013;63:64-5.
27. Wallace E, Salisbury C, Guthrie B, et al. Managing patients with multimorbidity in primary care. BMJ 2015;350.
28. Kroenke K, Spitzer R, Williams JB. The PHQ-9 validity of a Brief Depression Severity Measure. J Gen Intern Med 2001;16:606-13.
29. Year of Care: report of findings from the pilot programme. 2011. http://www.networks.nhs.uk/nhs-networks/national-pbc-clinicalleaders-network/documents/YOC-Report.pdf.
30. Hawe P, Shiell A, Riley T. Complex interventions: how "out of control" can a randomised controlled trial be? BMJ 2004;328:1561-3.
31. EuroQol Group. EuroQol Group EQ-5D-5L. Secondary EuroQol Group EQ-5D-5L. http://www.euroqol.org/about-eq-5d/valuation-of-eq-5d/eq-5d-5l-value-sets.html.
32. Mercer SW, McConnachie A, Maxwell M, et al. Relevance and practical use of the Consultation and Relational Empathy (CARE) measure in general practice. Fam Pract 2005;22:328-34.
33. Glasgow RE, Wagner EH, Schaefer J, et al. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care 2005;43:436-44.
34. Bayliss EA, Ellis JL, Steiner JF. Seniors' self-reported multimorbidity captured biopsychosocial factors not incorporated into two other data-based morbidity measures. J Clin Epidemiol 2009;62:550-7.e1.
35. Reeves D, Campbell SM, Adams J, et al. Combining multiple indicators of clinical quality-an evaluation of different analytic approaches. Med Care 2007;45:489-96.
36. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
37. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
38. Guthrie B, McCowan C, Davey P, et al. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ 2011;342:d3514.
39. AlJanabi H, Flynn TN, Coast J. Estimation of a preference-based carer experience scale. Med Decis Making 2011;31:458-68.
40. Bice TW, Boxerman SB. A quantitative measure of continuity of care. Med Care 1977;15:347-9.
41. Curtis L. Unit costs of health and social care. Canterbury, Kent: Personal Social Services Research Unit, 2012:1-272.
42. Department of Health. NHS Reference Costs. 2014. http://www.gov.uk/government/collections/nhs-reference-costs (accessed 10 Oct 2015).
43. British Medical Association, Royal Pharmaceutical Society. British National Formulary. London: BMJ Group and Pharmaceutical Press, 2015.
44. Kind P, Hardman G, Macran S. UK population norms for EQ-5D. York: University of York, 1999:98.
45. Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005;14:1523-32.
46. Kennedy A, Bower P, Reeves D, et al. Implementation of self management support for long term conditions in routine primary care settings: cluster randomised controlled trial. BMJ 2013;346:f2882.
47. Mann C, A Shaw A, Guthrie B, et al. Protocol for the process evaluation of a cluster randomised controlled trial to improve management of multi-morbidity in general practice (The 3D study). BMJ Open 2016. In press. doi:10.1136/bmjopen-2016-011260.
48. Loudon K, Treweek S, Sullivan F, et al. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ 2015;350:h2147.